Readmission rates within the first 30 and 90 days after severe COPD exacerbations (RACE study).

Saved in:
Bibliographic Details
Title: Readmission rates within the first 30 and 90 days after severe COPD exacerbations (RACE study).
Authors: Baydar Toprak O; Department of Chest Diseases, Faculty of Medicine, Cukurova University, Adana, Turkey., Polatli M; Department of Chest Diseases, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey., Baha A; Department of Chest Diseases, Near East University, Nicosia, Turkish Republic of Northern Cyprus., Kokturk N; Department of Chest Diseases, Faculty of Medicine, Gazi University, Ankara, Turkey., Yapar D; Department of Public Health, Turkish Ministry of Health, Muratpasa District Health Directorate, Antalya, Turkey.; Institute of Health Science Medical Informatics, Akdeniz University, Antalya, Turkey., Ozkan S; Department of Public Health, Faculty of Medicine, Gazi University, Ankara, Turkey., Sen E; Department of Chest Diseases, Faculty of Medicine, Ankara University, Ankara, Turkey., Ciftci F; Department of Chest Diseases, Faculty of Medicine, Ankara University, Ankara, Turkey., Ozturk B; Department of Chest Diseases, Faculty of Medicine, Gazi University, Ankara, Turkey., Kodalak S; Lutfi Kirdar Kartal Education and Research Hospital, Istanbul, Turkey., Ulubay G; Department of Chest Diseases, Faculty of Medicine, Baskent University, Ankara Hospital, Ankara, Turkey., Serifoglu I; Department of Chest Diseases, Faculty of Medicine, Baskent University, Ankara Hospital, Ankara, Turkey., Varol Y; Department of Chest Diseases, Izmir Health Sciences University, Suat Seren Chest Diseases and Surgery Training and Research Hospital, Izmir, Turkey., Mertoglu A; Department of Chest Diseases, Izmir Health Sciences University, Suat Seren Chest Diseases and Surgery Training and Research Hospital, Izmir, Turkey., Cirak AK; Department of Chest Diseases, Izmir Health Sciences University, Suat Seren Chest Diseases and Surgery Training and Research Hospital, Izmir, Turkey., Turan O; Department of Chest Diseases, Faculty of Medicine, Izmir Katip Celebi University, Izmir, Turkey., Dursunoglu N; Department of Chest Diseases, Faculty of Medicine, Pamukkale University, Denizli, Turkey., Savurmus N; Department of Chest Diseases, Faculty of Medicine, Pamukkale University, Denizli, Turkey., Gurgun A; Department of Chest Diseases, Faculty of Medicine, Ege University, Izmir, Turkey., Elmas F; Department of Chest Diseases, Faculty of Medicine, Ege University, Izmir, Turkey., Çoplu L; Department of Chest Diseases, Faculty of Medicine, Hacettepe University, Ankara, Turkey., Sertcelik U; Department of Chest Diseases, Faculty of Medicine, Hacettepe University, Ankara, Turkey., Yildiz R; Sureyyapaşa Chest Diseases and Surgery Training and Research Hospital, Clinics of Chest Diseases, Istanbul, Turkey., Ozmen I; Sureyyapaşa Chest Diseases and Surgery Training and Research Hospital, Clinics of Chest Diseases, Istanbul, Turkey., Alpaydin A; Department of Chest Diseases, Faculty of Medicine, Dokuz Eylül University, Izmir, Turkey., Karacay E; Ankara Senatorium Hospital, Ankara, Turkey., Celik D; Alanya University, Antalya, Turkey., Mete B; Department of Public Health, Faculty of Medicine, Cukurova University, Adana, Turkey.
Source: Medicine [Medicine (Baltimore)] 2024 Nov 29; Vol. 103 (48), pp. e40483.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1536-5964
DOI:10.1097/MD.0000000000040483